No Data
No Data
AnaptysBio Price Target Announced at $55.00/Share by HC Wainwright & Co.
AnaptysBio Price Target Announced at $55.00/Share by HC Wainwright & Co.
H.C. Wainwright Initiates AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $55
H.C. Wainwright analyst Emily Bodnar initiates coverage on $AnaptysBio(ANAB.US)$ with a buy rating, and sets the target price at $55.According to TipRanks data, the analyst has a success rate of 35.9%
AnaptysBio's Promising Pipeline and Rosnilimab's Best-in-Class Potential Justify Buy Rating
Express News | AnaptysBio Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Price Target $55
AnaptysBio Price Target Raised to $69.00/Share From $29.00 by JP Morgan
AnaptysBio Price Target Raised to $69.00/Share From $29.00 by JP
AnaptysBio Raised to Overweight From Neutral by JP Morgan
AnaptysBio Raised to Overweight From Neutral by JP